Edition:
United Kingdom

People: Agile Therapeutics Inc (AGRX.OQ)

AGRX.OQ on NASDAQ Stock Exchange Capital Market

1.42USD
22 Apr 2019
Change (% chg)

$0.04 (+2.90%)
Prev Close
$1.38
Open
$1.36
Day's High
$1.42
Day's Low
$1.36
Volume
7,825
Avg. Vol
82,130
52-wk High
$2.98
52-wk Low
$0.23

Garner, Elizabeth 

Ms.Elizabeth Garner, M.D., is Senior Vice President, Chief Medical Officer of Agile Therapeutics, Inc. Previously, she served as Vice President, Medical Affairs, Women's Health and Preventive Care at Myriad Genetics Laboratories from 2012 to 2014. From 2011 to 2012, she was Senior Medical Director, Women's Health at Abbott Laboratories where she served as the Clinical Lead, Endometriosis Program. Prior to that, Dr. Garner served as Associate Director and then Director, Vaccines Clinical Research at Merck Research Laboratories from 2007 to 2011. Dr. Garner received joint M.D. and M.P.H degrees from Harvard Medical School and the School of Public Health. She completed her residency in obstetrics and gynecology at Brigham and Women's/Massachusetts General Hospitals; her subspecialty fellowship in gynecologic oncology at Brigham and Women's and the Dana Farber Cancer Institute; and received board certification in both general Obstetrics and Gynecology and Gynecologic Oncology. Prior to entering the pharmaceutical industry, she had several years of experience in academic clinical practice, research and teaching at Harvard Medical School.

Basic Compensation

Total Annual Compensation, USD 369,500
Restricted Stock Award, USD 79,100
Long-Term Incentive Plans, USD --
All Other, USD 270,997
Fiscal Year Total, USD 719,597

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --